SCR-LIP-000634 · Claim · machine-readable JSON →

Macrophages in lipedema tissue are reported to show a predominantly alternatively activated, anti-inflammatory phenotype rather than a classical pro-inflammatory one.

General proposition consolidated from 5 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
low (GRADE)
Evidence
6 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20222026A distinct M2 macrophage infiltrate and transcriptomic profile decisively influence adipocyte differentiation in lipedema — Wolf et al. (2022) · consistentLipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis — Kruppa et al. (2023) · refiningTranscriptomics of Subcutaneous Tissue of Lipedema Identified Differentially Expressed Genes Involved in Adipogenesis, Inflammation, and Pain — Streubel et al. (2024) · consistentLipedema and adipose tissue: current understanding, controversies, and future directions — Rabiee (2025) · consistentLipedema: A Disease Triggered by M2 Polarized Macrophages? — Grewal et al. (2025) · refiningNew Frontiers in modeling the lipedema microenvironment in vitro — Soni & Abbott (2026) · consistent

Evidence (6)

Context (PECO)

Populationpatients with lipedema
Conditionlipedema
Exposurelipedema gfWAT
Comparatorcontrol / abdominal subcutaneous fat / lymphedema
OutcomeM2/CD163+ macrophage enrichment
Scopegluteofemoral adipose tissue

Answers these questions

Gaps & caveats

Change log